Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.O)

AUTL.O on Nasdaq

17.20USD
18 Jun 2019
Change (% chg)

$1.34 (+8.45%)
Prev Close
$15.86
Open
$16.18
Day's High
$17.34
Day's Low
$15.91
Volume
245,217
Avg. Vol
98,801
52-wk High
$53.24
52-wk Low
$15.07

About

Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product candidates target hematological cancers. Its products candidates include AUTO2,... (more)

Overall

Beta: --
Market Cap(Mil.): $703.32
Shares Outstanding(Mil.): 44.35
Dividend: --
Yield (%): --

Financials

  AUTL.O Industry Sector
P/E (TTM): -- 103.73 36.81
EPS (TTM): -- -- --
ROI: -- 7.70 12.05
ROE: -- 8.20 16.96

Earnings vs. Estimates